Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer
- DOI
- 10.1126/sciadv.aei1190
- Published
- 2026-09-04
- Container
- Science Advances
- Publisher
- American Association for the Advancement of Science (AAAS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1126/sciadv.aei1190,
title = {Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer},
author = {Felicia Zhang Perkins and Xiuli Zhang and Yik Yeung Lawrence Yu and Yilin Yang and Darren Cullinan and Kartik Singhal and Carlos A. Parra-Lopez and Christopher A. Miller and Binghan Yan and Julia W. Angkeow and Jinglun Li and Nancy B. Myers and Tammi Vickery and John Herndon and Rashmi Mishra and Stephanie Myles and Dominic Sanford and Elizabeth M. Jaffee and Daniel A. Laheru and Andrea Wang-Gillam and Marianna B. Ruzinova and Ian S. Hagemann and Sherri R. Davies and Timothy P. Fleming and Shelby Namen and Carl J. DeSelm and Lijin Li and Roheena Z. Panni and Feng Gao and Kian-Huat Lim and Obi L. Griffith and Malachi Griffith and Robert D. Schreiber and S. Peter Goedegebuure and William G. Hawkins and William E. Gillanders},
year = {2026},
journal = {Science Advances},
doi = {10.1126/sciadv.aei1190},
url = {https://doi.org/10.1126/sciadv.aei1190}
}RIS
TY - JOUR TI - Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer AU - Felicia Zhang Perkins AU - Xiuli Zhang AU - Yik Yeung Lawrence Yu AU - Yilin Yang AU - Darren Cullinan AU - Kartik Singhal AU - Carlos A. Parra-Lopez AU - Christopher A. Miller AU - Binghan Yan AU - Julia W. Angkeow AU - Jinglun Li AU - Nancy B. Myers AU - Tammi Vickery AU - John Herndon AU - Rashmi Mishra AU - Stephanie Myles AU - Dominic Sanford AU - Elizabeth M. Jaffee AU - Daniel A. Laheru AU - Andrea Wang-Gillam AU - Marianna B. Ruzinova AU - Ian S. Hagemann AU - Sherri R. Davies AU - Timothy P. Fleming AU - Shelby Namen AU - Carl J. DeSelm AU - Lijin Li AU - Roheena Z. Panni AU - Feng Gao AU - Kian-Huat Lim AU - Obi L. Griffith AU - Malachi Griffith AU - Robert D. Schreiber AU - S. Peter Goedegebuure AU - William G. Hawkins AU - William E. Gillanders PY - 2026 JO - Science Advances DO - 10.1126/sciadv.aei1190 UR - https://doi.org/10.1126/sciadv.aei1190 ER -
APA
Perkins, F. Z., Zhang, X., Yu, Y. Y. L., Yang, Y., Cullinan, D., Singhal, K., Parra-Lopez, C. A., Miller, C. A., Yan, B., Angkeow, J. W., Li, J., Myers, N. B., Vickery, T., Herndon, J., Mishra, R., Myles, S., Sanford, D., Jaffee, E. M., Laheru, D. A., Wang-Gillam, A., Ruzinova, M. B., Hagemann, I. S., Davies, S. R., Fleming, T. P., Namen, S., DeSelm, C. J., Li, L., Panni, R. Z., Gao, F., Lim, K., Griffith, O. L., Griffith, M., Schreiber, R. D., Goedegebuure, S. P., Hawkins, W. G., & Gillanders, W. E. (2026). Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer. Science Advances. https://doi.org/10.1126/sciadv.aei1190
Source records
- crossref · retrieved 2026-11-04T21:35:06.310Z